← AITECHHIVE

DEPLOYMENT · US

PARAMOUNT Trial: First Randomized Study Validates AI-Enabled Plaque-Based Care Protocol

PARAMOUNT, a randomized controlled trial, met its primary endpoint for AI-guided plaque detection and interventional care at AHA 2026. First large RCT validating AI decision support in cardiology procedural workflow.

WHY IT MATTERS · EDITORIAL ANALYSIS

RCT validation of AI in clinical workflows sets precedent for BFSI-adjacent insurance and healthcare finance; insurers can now cite peer-reviewed evidence for AI-driven underwriting and claims decisions.

Source: News-Press NOW · 2026-11-07

← BACK TO THE DAILY BRIEF

PARAMOUNT Trial: First Randomized Study Validates AI-Enabled Plaque-Based Care Protocol — AITechHive